Kyparissia (Kyp) Sirinakis - Profile and Investment Details

Investor Profile

Kyparissia (Kyp) Sirinakis is a Micro VC, Venture Capital, Private Equity Firm based in Bethesda, Maryland, United States with a diverse investment portfolio that includes companies such as Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics, Caldan Therapeutics, Theolytics, Macomics, Eternygen, NodThera, Clyde Biosciences, Enterprise Therapeutics, AdoRx Therapeutics, Apellis Pharmaceuticals, Mironid, Sirakoss, IGEM Therapeutics, Libra Therapeutics, Lunac Therapeutics. Over time, Kyparissia (Kyp) Sirinakis has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kyparissia (Kyp) Sirinakis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Chemical Engineering, Chemical, Life Science, Biotech, Healthcare, Biotechnology, Genomics, Medical, Therapeutics, Advanced Materials, Media and Entertainment may find it worthwhile to explore potential connections with Kyparissia (Kyp) Sirinakis, as their portfolio suggests a familiarity and interest in this area.

Understanding Kyparissia (Kyp) Sirinakis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.